quinoxalines has been researched along with ly 303070 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denizot, JP; Métin, C; Ropert, N | 1 |
Lindén, AM; Skolnick, P; Wheeler, WJ; Yu, H; Zarrinmayeh, H | 1 |
2 other study(ies) available for quinoxalines and ly 303070
Article | Year |
---|---|
Intermediate zone cells express calcium-permeable AMPA receptors and establish close contact with growing axons.
Topics: Action Potentials; Animals; Axons; Benzodiazepines; Biological Transport; Calbindins; Calcium; Cerebral Cortex; Cobalt; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Gestational Age; In Vitro Techniques; Kainic Acid; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; N-Methylaspartate; Neurites; Neurons; Prosencephalon; Quinoxalines; Receptors, AMPA; S100 Calcium Binding Protein G; Tetrodotoxin | 2000 |
Binding of an AMPA receptor potentiator ([3H]LY395153) to native and recombinant AMPA receptors.
Topics: Allosteric Site; Animals; Benzamides; Benzodiazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Sulfonamides; Tritium | 2001 |